Skin Elements (ASX:SKN) Notes Receivable: A$0.00 Mil (As of Dec. 2025)


What is Skin Elements Notes Receivable?

Skin Elements ASX:SKN -12.50% Notes Receivable is A$0.00 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Skin Elements's Notes Receivable for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Skin Elements Notes Receivable Historical Data

* Premium members only.

The historical data trend for Skin Elements's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skin Elements Notes Receivable Chart

Skin Elements Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Skin Elements Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Skin Elements Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of A$0.00 Mil mean?
Skin Elements (ASX:SKN) has a Notes Receivable of A$0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Skin Elements and its competitors.
Is Skin Elements' Notes Receivable too high?
Skin Elements' current Notes Receivable is A$0.00 Mil.
How does Skin Elements' Notes Receivable compare to PG and CL?
Skin Elements' Notes Receivable of A$0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Consumer Packaged Goods company?
A good Notes Receivable depends on the Consumer Packaged Goods industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Skin Elements and its competitors. Skin Elements's current Notes Receivable is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Elements stock overvalued right now?
Skin Elements (ASX:SKN) has a current Notes Receivable of A$0.00 Mil. The current Notes Receivable is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Skin Elements (ASX:SKN), the current Notes Receivable is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skin Elements Business Description

Address 1255A Hay Street, West Perth, Perth, WA, AUS, 6005
Skin Elements Ltd is a company that operates in the beauty and personal care industry. The principal business activities include the manufacture and distribution of natural, organic, health, and wellness products. Its brand portfolio includes Soleo Organics natural sunscreen brand, the PapayaActivs therapeutic skincare range, Elizabeth Jane Natural Cosmetics, and the recently developed Invisi-Shield SuprCuvr plant-based hospital-grade disinfectant range. The company has a single segment being research and development of the inventive proprietary SE Formula biotechnology.